FDG-PET predicts outcomes of treated bone metastasis following palliative radiotherapy in patients with hepatocellular carcinoma

2014 ◽  
Vol 34 (7) ◽  
pp. 1118-1125 ◽  
Author(s):  
Seo Hee Choi ◽  
Jee Suk Chang ◽  
Yong Hyu Jeong ◽  
Youngin Lee ◽  
Mijin Yun ◽  
...  
BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Li Zhang ◽  
Hao Niu ◽  
Ping Yang ◽  
Jie Ma ◽  
Bao-Ying Yuan ◽  
...  

Abstract Background Early screening and intervention therapies are crucial to improve the prognosis of hepatocellular carcinoma (HCC) patients with bone metastasis. We aimed to identify serum lncRNA as a prediction biomarker in HCC bone metastasis. Methods The expression levels of lnc34a in serum samples from 157 HCC patients were detected by quantitative real-time polymerase chain reaction (PCR). Univariate analysis and multivariate analysis were performed to determine statistically significant variables. Results Expression levels of lnc34a in serum from HCC patients with bone metastasis were significantly higher than those without bone metastasis. The high expressions of lnc34a, vascular invasion and Barcelona Clinic Liver Cancer (BCLC) stage were associated with bone metastasis by analysis. Moreover, lnc34a expression was specifically associated with bone metastasis rather than lung or lymph node metastasis in HCC. Conclusions High serum lnc34a expression was a independent risk factor for developing bone metastasis in HCC.


2020 ◽  
pp. 2001961
Author(s):  
Shuxia Zhang ◽  
Yingru Xu ◽  
Chan Xie ◽  
Liangliang Ren ◽  
Geyan Wu ◽  
...  

2018 ◽  
Vol 43 (12) ◽  
pp. e482-e483
Author(s):  
Raja Senthil ◽  
H Ramesh ◽  
Arun Visakh R. ◽  
Thara Pratap ◽  
Pushpa Mahadevan

2015 ◽  
Vol 36 (3) ◽  
pp. 226-233 ◽  
Author(s):  
Hyo Jung Seo ◽  
Gun Min Kim ◽  
Joo Hoon Kim ◽  
Won Jun Kang ◽  
Hye Jin Choi

Sign in / Sign up

Export Citation Format

Share Document